Parkinson’s Disease (PD) is the second most common neurogenerative disorder of aging and the most common movement disorder, but the cause of the disease is largely unknown.
A recent study from the University of Copenhagen found that the most common form of the disease, known as sporadic PD, is caused by a blockage of a pathway that regulates the nerve cell’s powerhouse, the mitochondria.
Just like when people eat, cells take what they need and get rid of the rest waste products.
But if the brain cells have this specific kind of signaling blockage, it means that the powerhouse of the cell—mitochondria—cannot get cleaned up after being damaged.
The researchers say that the blockage causes an accumulation of high amounts of damaged mitochondria, while not being able to produce enough energy for the cells.
It causes neurons to gradually die, which is the reason for the development of Parkinson’s Disease symptoms, and why it leads to dementia.
The blockage is caused by a dysregulation of the immune genes, which is normally important for fighting against viruses, but now researchers show that it is also responsible for regulating the energy supply of the nerve cells.
These pathways are very important for brain functions, but they are also linked to microbial and virus recognition.
For example, they are very important for fighting COVID-19, and a mutation in the related gene has been shown to be linked to a deadly outcome after contracting COVID-19.
In the study, the researchers combined and analyzed four data sets, which studied neurons from brains with Parkinson’s Disease and looked at what type of genes they express.
They then looked at which gene patterns were disturbed in patients with Parkinson’s Disease and especially those who had also developed PD with dementia.
They found that the accumulation of damaged mitochondrial mass leads to an increase in other toxic proteins.
When they compared patients to same-aged healthy patients without Parkinson’s Disease, they found that a protein called PIAS2 is highly expressed in the neurons.
They suggest this pathway should be evaluated for potential roles in the other forms of familial Parkinson’s Disease.
The team hopes the study will encourage research to counteract the pathway blockage, which could have a beneficial impact on the disease and on preventing dementia.
If you care about Parkinson’s disease, please read studies about Vitamin E that may help prevent Parkinson’s disease, and Vitamin D could benefit people with Parkinson’s disease.
For more information about brain health, please see recent studies about new way to treat Parkinson’s disease, and results showing flavonoid-rich foods could improve survival in Parkinson’s disease.
The study was conducted by Professor Shohreh Issazadeh-Navikas et al and published in Molecular Psychiatry.
Copyright © 2022 Knowridge Science Report. All rights reserved.